GlassScriptPhysician profile
Karla G Lessman
NPI 1528062239
$4,534.65
in general payments reported to CMS, 2019-2025
27 companies · $1,526 in 2025
The $1,526 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $339 · 2022: $508 · 2023: $1,297 · 2024: $865 · 2025: $1,526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,489 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,488.73 |
| Education | $199.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $861.22 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Jazz Pharmaceuticals INC. | $402.96 | 2021-2025 | |
| Grifols USA, LLC | $373.35 | 2021-2025 | Prolastin-C Liquid |
| Glaxosmithkline, LLC. | $338.50 | 2021-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $327.03 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $318.91 | 2022-2025 | Dupixent |
| Insmed, INC. | $233.85 | 2022-2025 | Arikayce, Brinsupri |
| Electromed, INC. | $222.01 | 2021-2025 | Smartvest |
| Amgen INC. | $211.43 | 2022-2025 | Tezspire, Tavneos |
| Takeda Pharmaceuticals U.S.A., INC. | $182.93 | 2021-2025 | Glassia, Aralast |
| Harmony Biosciences LLC | $174.48 | 2022-2025 | Wakix |
| United Therapeutics Corporation | $157.95 | 2021-2024 | Orenitram, Remodulin, Tyvaso |
| Actelion Pharmaceuticals US, INC. | $101.77 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Baxter Healthcare | $94.29 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $91.49 | 2022-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $69.67 | 2025 | Ohtuvayre |
| Genzyme Corporation | $59.45 | 2023-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $44.11 | 2024-2025 | Lumryz |
| Janssen Pharmaceuticals, INC | $41.95 | 2022-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $41.74 | 2022-2023 | |
| Axsome Therapeutics, INC. | $40.48 | 2022-2024 | Sunosi |
| Inspire Medical Systems, INC. | $38.94 | 2023 | Inspire |
| Mylan Specialty L.P. | $29.22 | 2021-2023 | Yupelri |
| Pharming Healthcare, INC. | $24.16 | 2023 | Ruconest |
| Lantheus Medical Imaging, INC. | $24.09 | 2024 | |
| Paratek Pharmaceuticals, INC. | $14.71 | 2022 | |
| Lilly USA, LLC | $13.96 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karla Lessman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.